Bruker
Prodotti e soluzioni Applicazioni Servizi News & Eventi Chi Siamo Lavora con noi
Utilizza almeno 2 caratteri (attualmente stai utilizzando 1 carattere).

Languages

Join us in Chicago, IL | July 27 - 31

ADLM 2025

Bringing Chromatography-free to the Masses: Explore the Future of Quantitative Analysis

Welcome to ADLM 2025

We are excited to invite you to the 2025 Annual Meeting of the Association for Diagnostics & Laboratory Medicine in Chicago, IL. This year’s conference is set to be a remarkable event, gathering leading experts, researchers, and industry professionals from across the globe.

Discover groundbreaking innovations in chromatography-free mass spectrometry and explore the latest technological advancements and methodologies in mass spectrometry, including cutting-edge data analytics, efficient sample preparation techniques, and stringent quality control measures.

Connect with our specialists: Stop by our booth #3653 to engage with our knowledgeable team, discuss your unique analytical challenges, and discover customized solutions to improve the efficiency of your lab.

We look forward to meeting you in Chicago and to discussing how our innovative solutions can meet your analytical requirements.

 

 

You can also follow us on LinkedIn for the latest updates and more information on our solutions.

ADLM 2025 

Bruker Booth #3653

July 27-31, 2025

McCormick Place Convention Center

2301 S Martin Luther King Dr

Chicago, IL 60616

If you want to learn more about our solutions or schedule a meeting at the ADLM with our team, please each out via email:

Contact Bruker Team
Rapid, Chromatography-Free Screening

We make it easier to screen your samples.

And, save time and money in the process. See how you can elevate your analysis.

 

Rapid chromatography-free screens and chromatography-free quantitation enabled by DART-MS: the EVOQ® DART-TQ+ is designed to deliver exceptional analytical performance day in, day out.

EVOQ® DART-TQ+ is the world’s first triple quadrupole MS system specifically designed for DART ion source plug-and-play operation, allowing seamless source parameters and automation control in routine laboratory environments.

Learn more Download brochure
Direct Analysis in Real Time Mass Spectrometry

DART-MS - Analyze More, Faster

Learn more

Faster, greener, reliable analysis with minimal sample prep – completely chromatography-free mass spectrometry with an ion source that gets you there.

 

DART-MS (Direct Analysis in Real Time Mass Spectrometry) is a groundbreaking ionization technology that simplifies and accelerates chemical analysis. It allows for the rapid examination of solids, liquids, and gases in their natural state with minimal sample preparation. By eliminating the need for chromatography during analysis, DART-MS ensures a straightforward, rapid approach to chemical testing.

Further Resources

Interview

Bruker’s Investment in RECIPE Expands Access to Chromatography-Free MS

Bruker’s new partnership will accelerate mass spectrometry use in clinical diagnostics research and toxicology screening.
Read the article
App Note

Analysis of Antimycotics Using the Bruker EVOQ® DART-TQ+

This study presents the results obtained for the analysis of 8 antimycotics in serum with the ClinMass® TDM Platform MS9000 and the ClinMass® Add-on Set MS9600 (RECIPE Chemicals + Instruments GmbH, Munich)
Download App Note
App Note

A new paradigm in forensic analysis

DART-MS enables the rapid chromatography-free analysis of seized drugs. aration and analysis time, ultimately shortening response time and increasing throughput. Direct Analysis in Real Time-Mass Spectrometry (DART-MS) as Bruker’s unique Point-of-Need (PoN) workflow allows for quick and easy generation of useful information and increased productivity in labs.
Download App Note
Press Release

Bruker Announces Majority Acquisition of RECIPE

Bruker and RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring, are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays.
Read Press release
App Note

Rapid Chromatography-Free Screening of Benzodiazepine Drugs and Metabolites

Analysis of urine-based benzodiazepine drugs and associated metabolites using the EVOQ® DART-TQ+ mass spectrometer with a Direct Analysis in Real Time (DART) ion source provides rapid and accurate quantitative confirmatory screening results in a chromatography-free workflow.
Download App Note
App note    

DART-HRMS for the rapid screening of seized drugs: A study on authentic paper samples

Increased backlogs of seized drug samples, long turnaround times and the appearance of a high number of NPS are key challenges within the forensic community worldwide. This application note showcases a comprehensive workflow featuring DART-HRMS, specifically tailored to address these challenges.
Read App Note
Interview

Bruker tackles drugs of abuse and POPs issues

Are you curious about the latest advancements in drug screening, sustainable analytical methods, and high-resolution screening? Jeffrey Zonderman talked to SelectScience® and shared insights on solutions for drugs of abuse screening and POPs analysis, greener and more efficient alternatives to chromatographic methods and untargeted High-Resolution screening.
Watch Interview

 

For Research Use Only. Not for use in clinical diagnostic procedures.